Author:
Teira Ramón,Diaz-Cuervo Helena,Aragão Filipa,Castaño Manuel,Romero Alberto,Roca Bernardino,Montero Marta,Galindo Maria José,Muñoz-Sánchez Maria Jose,Espinosa Nuria,Peraire Joaquim,Martínez Elisa,de la Fuente Belén,Domingo Pere,Deig Elisabeth,Merino María Dolores,Geijo Paloma,Estrada Vicente,Sepúlveda María Antonia,García Josefina,Berenguer Juan,Currán Adriá
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Reference44 articles.
1. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. World Health Organization, Geneva. 2021. https://www.who.int/publications/i/item/9789240027077. Accessed December 10, 2021.
2. Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016;139:3–12.
3. Sabin CA, Lundgren JD. The natural history of HIV infection. Curr Opin HIV AIDS. 2013;8(4):311–7.
4. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet. 1996;348(9023):283–91.
5. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med. 1996;335(15):1081–90.